Board Meeting6 Nov 2026, 11:48 am
Aptus Pharma Board Meeting on Nov 12 for Preferential Allotment
AI Summary
Aptus Pharma Ltd has announced a Board of Directors meeting scheduled for November 12, 2026. The primary agenda is to consider and approve the allotment of equity shares on a preferential basis. This allotment follows shareholder approval at the AGM on September 14, 2026, and in-principle approval from BSE on October 30, 2026. The allotment is contingent upon receiving subscription money and fulfilling all statutory and regulatory requirements.
Key Highlights
- Board meeting scheduled for November 12, 2026.
- To consider preferential allotment of equity shares.
- Allotment requires subscription money and regulatory compliance.
- Shareholder and BSE approvals are already in place.
Price Impact
More from APPL